Skip to Main content Skip to Navigation
Journal articles

Allergen-derived peptide: A promising approach in asthma

Abstract : Severe asthma required high dose of corticosteroids combined with biotherapies to control more or less asthma symptoms and lead to the decrease of patients' quality of life on long term. Recent studies show that hypoallergenic peptides derived from allergen can prevent airway hyperresponsiveness, decrease Th2 response and also allergen-specific IgE in mouse models of allergic asthma. Even if some peptides mechanisms remain unknown, their fast efficacy with low doses of allergens make peptide immunotherapy a new promising approach in allergic asthma.
Complete list of metadata
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Friday, October 22, 2021 - 9:36:07 PM
Last modification on : Wednesday, November 3, 2021 - 6:12:52 AM


Files produced by the author(s)


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License




M. Klein, Axel Magnan, Grégory Bouchaud. Allergen-derived peptide: A promising approach in asthma. Revue des Maladies Respiratoires, Elsevier Masson, 2019, 36 (4), pp.442-446. ⟨10.1016/j.rmr.2019.03.005⟩. ⟨hal-02619077⟩



Les métriques sont temporairement indisponibles